BlackRock Advisors LLC cut its position in Xylem Inc. (NYSE:XYL) by 3.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 257,045 shares of the company’s stock after selling 9,756 shares during the period. BlackRock Advisors LLC owned approximately 0.14% of Xylem worth $11,477,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Aperio Group LLC raised its stake in Xylem by 12.1% in the first quarter. Aperio Group LLC now owns 116,622 shares of the company’s stock worth $4,770,000 after buying an additional 12,566 shares during the period. Nisa Investment Advisors L.L.C. raised its stake in Xylem by 10.9% in the first quarter. Nisa Investment Advisors L.L.C. now owns 50,771 shares of the company’s stock worth $2,077,000 after buying an additional 5,000 shares during the period. Virginia Retirement System acquired a new stake in Xylem during the first quarter worth $360,000. Pacad Investment Ltd. acquired a new stake in Xylem during the first quarter worth $249,000. Finally, Ngam Advisors L.P. raised its stake in Xylem by 3.7% in the first quarter. Ngam Advisors L.P. now owns 17,552 shares of the company’s stock worth $718,000 after buying an additional 629 shares during the period. 84.70% of the stock is owned by institutional investors.
Xylem Inc. (NYSE:XYL) opened at 51.83 on Friday. The firm has a market cap of $9.29 billion, a P/E ratio of 27.67 and a beta of 1.15. Xylem Inc. has a one year low of $31.67 and a one year high of $53.25. The company has a 50-day moving average of $51.02 and a 200 day moving average of $46.06.
Xylem (NYSE:XYL) last released its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.01. The company earned $932 million during the quarter, compared to the consensus estimate of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. Xylem’s revenue was up 1.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.43 EPS. Equities research analysts expect that Xylem Inc. will post $2.04 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 21st. Shareholders of record on Wednesday, August 31st were given a $0.1549 dividend. This represents a $0.62 annualized dividend and a yield of 1.20%. The ex-dividend date was Monday, August 29th. Xylem’s dividend payout ratio is currently 33.16%.
XYL has been the subject of a number of research reports. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $52.00 price objective (up from $46.00) on shares of Xylem in a research note on Monday, June 20th. Zacks Investment Research lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Barclays PLC increased their price target on shares of Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research report on Monday, July 18th. Royal Bank Of Canada increased their price target on shares of Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a research report on Tuesday, August 16th. Finally, RBC Capital Markets set a $51.00 price target on shares of Xylem and gave the company a “buy” rating in a research report on Tuesday, August 16th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $45.00.
In other news, Director Steven R. Loranger sold 33,887 shares of the business’s stock in a transaction dated Thursday, August 11th. The stock was sold at an average price of $48.11, for a total transaction of $1,630,303.57. Following the completion of the transaction, the director now directly owns 11,243 shares of the company’s stock, valued at $540,900.73. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Colin R. Sabol sold 27,473 shares of the business’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the transaction, the insider now directly owns 65,530 shares of the company’s stock, valued at $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is owned by company insiders.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.